Skip to main content
Top PicksResearch
TransMedics Group logo
TMDX.NASDAQ
TransMedics Group
Healthcare · Medical Devices
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.MoreShow less
HQ: United StatesListed: United States

Forecast History

Audit every published iPulse AI forecast batch and immutable historical research document for TransMedics Group.

Public accountability ledgerTMDX.NASDAQ

TransMedics Group Forecast History

iPulse AI is an open and transparent investment research platform. Every published forecast is preserved as an immutable, inspectable record, so anyone can revisit what was predicted, when it was published, and how it performed.

Published batches

3

Latest deep analysis

Jul 5, 2026

Looking for the current research rather than an archived batch?

Latest AI ConsensusLatest AI Forecasts

Immutable research archive

Forecast batch ledger

Select a dated batch to open the complete historical AI Consensus or AI Forecasts workspace. Forecasts stay frozen at their original anchor. Latest-batch performance was refreshed Aug 1, 2026 based on the closing price from Jul 31, 2026.

Immutable iPulse AI forecast batches for TransMedics Group
BatchVersionPublishedForecast anchorReturn updateAdvisorsResearch documents
Batch 6(Latest)
Updated performanceRefreshed dailyJul 5, 2026Jul 2, 2026Refreshed Aug 1, 2026Based on closing price Jul 31, 202612
AI ConsensusAI Forecasts
Historical recordImmutableAs originally publishedOriginal pricing basis
AI ConsensusAI Forecasts
Batch 5Historical recordImmutableJun 5, 2026Jun 4, 2026Actuals through Jul 31, 2026Forecast unchanged12
AI ConsensusAI Forecasts
Batch 4Historical recordImmutableMay 3, 2026May 1, 2026Actuals through Jul 31, 2026Forecast unchanged11
AI Consensusnot publishedAI Forecasts